137 related articles for article (PubMed ID: 22582788)
1. Treatment outcomes and predictors for systemic steroids in nasal polyposis.
Won TB; Jang E; Min SK; Kim SW
Acta Otolaryngol; 2012 Jun; 132 Suppl 1():S82-7. PubMed ID: 22582788
[TBL] [Abstract][Full Text] [Related]
2. Olfaction in patients with nasal polyposis: effects of systemic steroids and radical ethmoidectomy with middle turbinate resection (nasalization).
Jankowski R; Bodino C
Rhinology; 2003 Dec; 41(4):220-30. PubMed ID: 14750349
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy of a short course of systemic steroids in nasal polyposis.
Kirtsreesakul V; Wongsritrang K; Ruttanaphol S
Rhinology; 2011 Dec; 49(5):525-32. PubMed ID: 22125782
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of systemic steroid treatment in sinonasal polyposis.
Berkiten G; Salturk Z; Topaloğlu I
J Craniofac Surg; 2013 May; 24(3):e305-8. PubMed ID: 23715001
[TBL] [Abstract][Full Text] [Related]
5. Predictors of bronchial hyperresponsiveness in chronic rhinosinusitis with nasal polyp.
Han DH; Kim SW; Cho SH; Kim DY; Lee CH; Kim SS; Rhee CS
Allergy; 2009 Jan; 64(1):118-22. PubMed ID: 19120071
[TBL] [Abstract][Full Text] [Related]
6. Evaluating budesonide efficacy in nasal polyposis and predicting the resistance to treatment.
Valera FC; Queiroz R; Scrideli C; Tone LG; Anselmo-Lima WT
Clin Exp Allergy; 2009 Jan; 39(1):81-8. PubMed ID: 19068102
[TBL] [Abstract][Full Text] [Related]
7. Influence of allergy on the symptoms and treatment of nasal polyposis.
Bonfils P; Avan P; Malinvaud D
Acta Otolaryngol; 2006 Aug; 126(8):839-44. PubMed ID: 16846927
[TBL] [Abstract][Full Text] [Related]
8. Influence of allergy on clinical, immunological and histological characteristics of nasal polyposis.
Perić A; Vojvodić D; Vukomanović-Durdevid B
B-ENT; 2012; 8(1):25-32. PubMed ID: 22545387
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of pulmonary function in patients with nasal polyposis.
Lamblin C; Brichet A; Perez T; Darras J; Tonnel AB; Wallaert B
Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 1):406-13. PubMed ID: 10673178
[TBL] [Abstract][Full Text] [Related]
10. Regulation of glucocorticoid receptor in nasal polyps by systemic and intranasal glucocorticoids.
Pujols L; Alobid I; Benítez P; Martínez-Antón A; Roca-Ferrer J; Fokkens WJ; Mullol J; Picado C
Allergy; 2008 Oct; 63(10):1377-86. PubMed ID: 18671773
[TBL] [Abstract][Full Text] [Related]
11. Significance of nasal polyps in chronic rhinosinusitis: symptoms and surgical outcomes.
Deal RT; Kountakis SE
Laryngoscope; 2004 Nov; 114(11):1932-5. PubMed ID: 15510016
[TBL] [Abstract][Full Text] [Related]
12. Outcomes after endoscopic sinus surgery for unilateral versus bilateral chronic rhinosinusitis with nasal polyposis.
Lee JY; Byun JY; Shim SS; Lee SW
Am J Rhinol Allergy; 2010; 24(3):83-6. PubMed ID: 20537280
[TBL] [Abstract][Full Text] [Related]
13. Adrenal suppression and osteoporosis after treatment of nasal polyposis.
Bonfils P; Halimi P; Malinvaud D
Acta Otolaryngol; 2006 Dec; 126(11):1195-200. PubMed ID: 17050313
[TBL] [Abstract][Full Text] [Related]
14. Proinflammatory cytokine levels in nasal fluid as indicators of severity of nasal polyposis.
Perić A; Vojvodić D; Radulović V; Vukomanović-Durdević B; Perić AV; Miljanović O
Acta Clin Croat; 2010 Dec; 49(4):395-403. PubMed ID: 21830450
[TBL] [Abstract][Full Text] [Related]
15. Effect of montelukast on quality of life in subjects with nasal polyposis accompanying bronchial asthma.
Yazıcı ZM; Sayın I; Bozkurt E; Kayhan FT
Kulak Burun Bogaz Ihtis Derg; 2011; 21(4):210-4. PubMed ID: 21762051
[TBL] [Abstract][Full Text] [Related]
16. Evolution of symptoms associated to nasal polyposis following oral steroid treatment and nasalization of the ethmoid--radical ethmoidectomy is functional surgery for NPS.
Jankowski R; Bodino C
Rhinology; 2003 Dec; 41(4):211-9. PubMed ID: 14750348
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the surgical outcome between primary and revision endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis.
Lee JY; Lee SW; Lee JD
Am J Otolaryngol; 2008; 29(6):379-84. PubMed ID: 19144298
[TBL] [Abstract][Full Text] [Related]
18. Airway inflammation in nasal polyposis: immunopathological aspects of relation to asthma.
Ediger D; Sin BA; Heper A; Anadolu Y; Misirligil Z
Clin Exp Allergy; 2005 Mar; 35(3):319-26. PubMed ID: 15784110
[TBL] [Abstract][Full Text] [Related]
19. Effect of long-term, low-dose clarithromycin on T helper 2 cytokines, eosinophilic cationic protein and the 'regulated on activation, normal T cell expressed and secreted' chemokine in the nasal secretions of patients with nasal polyposis.
Perić A; Vojvodić D; Matković-Jožin S
J Laryngol Otol; 2012 May; 126(5):495-502. PubMed ID: 22559798
[TBL] [Abstract][Full Text] [Related]
20. GRbeta expression in nasal polyp inflammatory cells and its relationship to the anti-inflammatory effects of intranasal fluticasone.
Hamilos DL; Leung DY; Muro S; Kahn AM; Hamilos SS; Thawley SE; Hamid QA
J Allergy Clin Immunol; 2001 Jul; 108(1):59-68. PubMed ID: 11447383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
